-
EDITORIAL
Peptides and Oligonucleotides, common trends as drugs
F. Albericio
-
COMPANY PROFILE
Procos’ HPAPI unit expansion & future investments
-
PANEL DISCUSSION ON PEPTIDES
W. Cabri
-
OLIGONUCLEOTIDES & PEPTIDES
Oligonucleotides: Right Place, Right time, Right future
T. Martinez
-
OLIGONUCLEOTIDES & PEPTIDES
Oligonucleotide therapeutics. A long and windy road towards future medicines
R. Eritja, C. Fabrega
-
OLIGONUCLEOTIDES & PEPTIDES
Synthetic Chemistry in Nucleic Acid Drugs Recent progress in bridged nucleic acids (BNA)
K. Okano
-
A WORD WITH
Kathy Ackley, Oligonucleotide CMC Consultant
-
Column: REGULATION
Regulatory toxicology: more experts needed
A. Conto
-
COLUMN: API OF THE MONTH
Pirtobrutinib
R. Souza
-
PANEL DISCUSSION ON OLIGONUCLEOTIDES AND THERAPEUTICS
B. Morimoto
